90% of drug candidates fail in clinical trials. This leads to billions of dollars and thousands of hours wasted on drugs that never advance. CAS BioFinder empowers your medicinal chemists with the predictive screening tools, SAR data, and drug optimization capabilities to invest their valuable time and resources in only the most promising candidates.
Your medicinal chemistry team can spend weeks searching disconnected literature sources to create a promising candidate set for HTS. CAS BioFinder cuts that time drastically by allowing you to search through and filter thousands of ligand-target-disease combinations in seconds—all from our expert-curated data. This results in a more precise, curated candidate list in a fraction of the time before you get to the lab.
Advancing small molecules from idea to candidate hinges on speed, clarity, and early high-stakes decisions. Our white paper maps out five data challenges slowing your R&D endeavors to help you identify friction points, explore actionable solutions, and uncover a path to design decisions in small molecule drug discovery.
Medicinal chemistry should not happen in isolation. It requires detailed pathway information, disease mechanisms, and biomarker contexts that all contribute to effective drug optimization. Ensure your team has access to the right data and tools to inform smarter optimization decisions.
Give your candidates a stronger route to success from candidate selection to preparation for clinical trials.
See how we support drug discovery
